Human Umbilical Cord Blood Cell Grafts for Brain Ischemia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Dong-Hyuk | - |
dc.contributor.author | Borlongan, Cesar V. | - |
dc.contributor.author | Willing, Alison E. | - |
dc.contributor.author | Eve, David J. | - |
dc.contributor.author | Cruz, L. Eduardo | - |
dc.contributor.author | Sanberg, Cyndy D. | - |
dc.contributor.author | Chung, Yong-Gu | - |
dc.contributor.author | Sanberg, Paul R. | - |
dc.date.accessioned | 2021-09-08T21:22:01Z | - |
dc.date.available | 2021-09-08T21:22:01Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 0963-6897 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/120910 | - |
dc.description.abstract | Irreversible and permanent damage develop immediately adjacent to the region of reduced cerebral blood perfusion in stroke patients. Currently, the proven thrombolytic treatment for stroke, tissue plasminogen activator, is only effective when administered within 3 It after stroke. These disease characteristics should be taken under consideration in developing any therapeutic intervention designed to widen the narrow therapeutic range, especially cell-based therapy. Over the past several years, our group and others have characterized the therapeutic potential of human umbilical cord blood cells for stroke and other neurological disorders using in vitro and vivo models focusing on the cells' ability to differentiate into nonhematopoietic cells including neural lineage, as well as their ability to produce several neurotrophic factors and modulate immune and inflammatory reaction. Rather than the conventional cell replacement mechanism, we advance alternative pathways of graft-mediated brain repair involving neurotrophic effects resulting from release of various growth factors that afford cell survival, angiogenesis, and anti-inflammation. Eventually, these multiple protective and restorative effects from umbilical cord blood cell grafts may be interdependent and act in harmony in promoting therapeutic benefits for stroke. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS INC | - |
dc.subject | EX-VIVO EXPANSION | - |
dc.subject | MARROW STROMAL CELLS | - |
dc.subject | HEMATOPOIETIC STEM-CELLS | - |
dc.subject | MESENCHYMAL PROGENITOR CELLS | - |
dc.subject | VERSUS-HOST-DISEASE | - |
dc.subject | BONE-MARROW | - |
dc.subject | CEREBRAL-ISCHEMIA | - |
dc.subject | IN-VITRO | - |
dc.subject | CD34(+) CELLS | - |
dc.subject | GROWTH-FACTOR | - |
dc.title | Human Umbilical Cord Blood Cell Grafts for Brain Ischemia | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Dong-Hyuk | - |
dc.identifier.doi | 10.3727/096368909X471279 | - |
dc.identifier.wosid | 000273699100004 | - |
dc.identifier.bibliographicCitation | CELL TRANSPLANTATION, v.18, no.9, pp.985 - 998 | - |
dc.relation.isPartOf | CELL TRANSPLANTATION | - |
dc.citation.title | CELL TRANSPLANTATION | - |
dc.citation.volume | 18 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 985 | - |
dc.citation.endPage | 998 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalResearchArea | Transplantation | - |
dc.relation.journalWebOfScienceCategory | Cell & Tissue Engineering | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.relation.journalWebOfScienceCategory | Transplantation | - |
dc.subject.keywordPlus | EX-VIVO EXPANSION | - |
dc.subject.keywordPlus | MARROW STROMAL CELLS | - |
dc.subject.keywordPlus | HEMATOPOIETIC STEM-CELLS | - |
dc.subject.keywordPlus | MESENCHYMAL PROGENITOR CELLS | - |
dc.subject.keywordPlus | VERSUS-HOST-DISEASE | - |
dc.subject.keywordPlus | BONE-MARROW | - |
dc.subject.keywordPlus | CEREBRAL-ISCHEMIA | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | CD34(+) CELLS | - |
dc.subject.keywordPlus | GROWTH-FACTOR | - |
dc.subject.keywordAuthor | Angiogenesis | - |
dc.subject.keywordAuthor | Human umbilical cord blood cells | - |
dc.subject.keywordAuthor | Inflammation | - |
dc.subject.keywordAuthor | Middle cerebral artery occlusion | - |
dc.subject.keywordAuthor | Neurogenesis | - |
dc.subject.keywordAuthor | Stroke | - |
dc.subject.keywordAuthor | Transplantation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.